J.P. Morgan Securities LLC
383 Madison Avenue
New York, NY 10179
Credit Suisse Securities (USA) LLC
Eleven Madison Avenue
New York, NY 10010
June 13, 2014
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
| Attention: | Jeffrey P. Riedler, Assistant Director |
Scott Wuenschell
Joel Parker
Christina De Rosa
Dan Greenspan
| Re: | ZS Pharma, Inc. |
Registration Statement on Form S-1
Filed on May 15, 2014
Registration File No. 333-195961
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned, as representatives of the several underwriters (the “Underwriters”), hereby join in the request of ZS Pharma, Inc. (the “Company”) for acceleration of the effective date of the above-referenced registration statement so that it becomes effective at 1:00 p.m., Eastern time, on June 17, 2014, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, please be advised that there will be distributed to each Underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned advise that they have complied and will continue to comply, and each Underwriter and dealer has advised the undersigned that it has complied and will continue to comply, with Rule 15c2-8 under the Securities Exchange Act of 1934.
[Signature page follows]
| Very truly yours, | ||
J.P. MORGAN SECURITIES LLC CREDIT SUISSE SECURITIES (USA) LLC
Acting severally on behalf of themselves and the several Underwriters | ||
| By: | J.P. MORGAN SECURITIES LLC | |
| By: | /s/ Benjamin Burdett | |
| Benjamin Burdett | ||
| Vice President | ||
| By: | CREDIT SUISSE SECURITIES (USA) LLC | |
| By: | /s/ Kristin DeClark | |
| Kristin DeClark | ||
| Director | ||
[Signature page to Underwriters’ Acceleration Request]
